Please ensure Javascript is enabled for purposes of website accessibility

Bank Stocks Drag Down the Dow

By Travis Hoium - Apr 3, 2013 at 3:33PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Weak economic data has investors rethinking their bullishness on bank stocks.

It took a few hours to sink in, but investors sold off stocks after some weak economic data was reported this morning. ADP payroll data for March showed a 158,000 increase in jobs, which fell far short of both February's 237,000 and the estimate of 200,000. So far we're overlooking the fact that ADP revised February numbers higher by 39,000 and projecting the possibility of a weak jobs report on Friday.

The other data point worrying investors is ISM's nonmanufacturing index, which fell to 54.4 in March, below the 55.8 estimate. This still signals expansion but shows more weakness in the economy than it did a month ago and adds to weak manufacturing readings over the past few weeks. With about half an hour left in the trading day, the Dow Jones Industrial Average (^DJI 1.76%) has fallen 0.68%, and the S&P 500 (^GSPC 2.47%) is down 1%.

Bank of America (BAC 0.95%) and JPMorgan Chase (JPM 1.41%) have done the most damage to the Dow, falling 3% and 2.6%, respectively. One of the concerning numbers in ADP's report was a slowdown in construction hiring, which has driven a lot of the economic recovery. Both megabanks are tied closely to housing, and increased construction signals a healthy housing market, so a slowdown is troublesome. Keep in mind that this is just one data point, and many economists weren't expecting the economy to really pick up steam until the second half of the year, when the impact of tax increases and the sequester are no longer on the minds of consumers and businesses.

Merck (MRK 0.83%) is one of just four Dow components moving higher today, up 1.1%. There are likely two factors driving Merck higher today. First is the increase in Medicare Advantage reimbursements announced yesterday, which should keep Merck from feeling a bigger pinch from insurers. The second factor is that Merck is in a business that sees few swings in demand based on the economy. Investors are fleeing to stocks that won't be hurt if the economy slows over the next few quarters, and Merck is a beneficiary of that flow of money today.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Dow Jones Industrial Average (Price Return) Stock Quote
Dow Jones Industrial Average (Price Return)
$33,212.96 (1.76%) $575.77
Bank of America Corporation Stock Quote
Bank of America Corporation
$37.02 (0.95%) $0.35
JPMorgan Chase & Co. Stock Quote
JPMorgan Chase & Co.
$131.27 (1.41%) $1.83
Merck & Co., Inc. Stock Quote
Merck & Co., Inc.
$93.08 (0.83%) $0.77
S&P 500 Index - Price Return (USD) Stock Quote
S&P 500 Index - Price Return (USD)
$4,158.24 (2.47%) $100.40

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.